Skip to content

Effect of Irsal-e-Alaq (Leech Therapy) in Management of Niqris (Gout)

Clinical Evaluation of the Effect of Irsal-e-Alaq (Leech Therapy) in the Management of Niqris (Gout) - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/057624
Enrollment
40
Registered
2023-09-14
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

Intervention1: Leech Therapy along with Habb-e-Suranjan 2 tablets twice daily: 4-6 Leeches will be applied on the affected joint for 30 minutes twice weekly for 4 weeks along with two Tablets Habb-e-S

Sponsors

Aligarh Muslim University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of Gout Patients willing to give informed written consent

Exclusion criteria

Exclusion criteria: Patients below the age of 25 and above the age of 65 years Patients with uncontrolled Diabetes Mellitus & Hypertension Pregnant and lactating patients Patients with systemic disorders like Chronic Renal Failure & Coronary Artery Disease Diagnosed cases of Osteoarthritis and Rheumatoid Arthritis Patients having malignancy, psychological disorder Patients taking Pyrazinamide Immunocompromised patients Patients of bleeding disorders, severe anaemia, hypotension. Patients having allergy to leech Patients who refuse to sign the consent

Design outcomes

Primary

MeasureTime frame
VAS Serum uric acid levelTimepoint: Assessment on Baseline 14th day 28th day

Secondary

MeasureTime frame
Gout Impact Scale Tenderness Stiffness Swelling Redness Temperature of affected joint Restriction of movementTimepoint: Assessment on Baseline 14th day 28th day

Countries

India

Contacts

Public ContactSHAZIYA BEGUM

Aligarh Muslim University

drmshoaib77@gmail.com9411491568

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026